1-3 of 3
Kenneth Cohen, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I/II Clinical Trial of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas

Ajay Major, MDMBA, Justin Kline, MD, Theodore G. Karrison, PhD, Paul A S Fishkin, MD, Amy S Kimball, MD PhD, Adam M Petrich, MD, Sreenivasa Nattam, MD, Bethany G Sleckman, MD, Kenneth Cohen, MD, Koen van Besien, MD PhD, Aaron P. Rapoport, MD, Sonali M. Smith, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-134750
Published: 2020
Journal Articles

A Pilot Study of a Functional Pain Assessment for Adult Patients Admitted with Sickle Cell Pain Crisis

Marquita Nelson, MD, Monica Peek, MDMPH, Kenneth Cohen, MD, Danielle Bowsman, MHA, Nabil Abou-Baker, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4693.
https://doi.org/10.1182/blood-2019-124847
Published: 2019
Journal Articles

Prospective Phase I Multi-Center Trial Incorporating Lenalidomide (LEN) into Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Patients with Double Hit (DHL) or Double Expressing (DEL) Lymphomas: Final Results

Chadi Nabhan, MD MBA, FACP, Theodore Karrison, PhD, Justin Kline, Kenneth Cohen, MD, Michael R. Bishop, MD, Reem Karmali, MD MS, Aaron P. Rapoport, MD, Parameswaran Venugopal, MD, James Wade, MD, Paul Fishkin, MD, Sonali M. Smith, MD
Journal: Blood
Blood (2016) 128 (22): 4191.
https://doi.org/10.1182/blood.V128.22.4191.4191
Published: 2016